Glenn R. Mattes - Net Worth and Insider Trading
Glenn R. Mattes Net Worth
The estimated net worth of Glenn R. Mattes is at least $2,890 dollars as of 2024-11-10. Glenn R. Mattes is the President and CEO of TFF Pharmaceuticals Inc and owns about 1,720 shares of TFF Pharmaceuticals Inc (TFFP) stock worth over $2,890. Details can be seen in Glenn R. Mattes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn R. Mattes has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Glenn R. Mattes
Glenn R. Mattes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Glenn R. Mattes owns 2 companies in total, including TFF Pharmaceuticals Inc (TFFP) , and Arno Therapeutics Inc (ARNI) .
Click here to see the complete history of Glenn R. Mattes’s form 4 insider trades.
Insider Ownership Summary of Glenn R. Mattes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TFFP | TFF Pharmaceuticals Inc | 2022-05-16 | director & President and CEO |
ARNI | Arno Therapeutics Inc | 2014-01-24 | director & President & CEO |
Glenn R. Mattes Latest Holdings Summary
Glenn R. Mattes currently owns a total of 1 stock. Glenn R. Mattes owns 1,720 shares of TFF Pharmaceuticals Inc (TFFP) as of May 16, 2022, with a value of $2,890.
Latest Holdings of Glenn R. Mattes
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TFFP | TFF Pharmaceuticals Inc | 2022-05-16 | 1,720 | 1.68 | 2,890 |
Holding Weightings of Glenn R. Mattes
Glenn R. Mattes Form 4 Trading Tracker
According to the SEC Form 4 filings, Glenn R. Mattes has made a total of 7 transactions in TFF Pharmaceuticals Inc (TFFP) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in TFF Pharmaceuticals Inc is the acquisition of 640 shares on May 16, 2022, which cost Glenn R. Mattes around $76,480.
Insider Trading History of Glenn R. Mattes
- 1
Glenn R. Mattes Trading Performance
GuruFocus tracks the stock performance after each of Glenn R. Mattes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn R. Mattes is 4.06%. GuruFocus also compares Glenn R. Mattes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn R. Mattes within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Glenn R. Mattes's insider trading performs compared to the benchmark.
Performance of Glenn R. Mattes
Glenn R. Mattes Ownership Network
Ownership Network List of Glenn R. Mattes
Ownership Network Relation of Glenn R. Mattes
Glenn R. Mattes Owned Company Details
What does TFF Pharmaceuticals Inc do?
Who are the key executives at TFF Pharmaceuticals Inc?
Glenn R. Mattes is the director & President and CEO of TFF Pharmaceuticals Inc. Other key executives at TFF Pharmaceuticals Inc include 10 percent owner Carlson Capital L P , 10 percent owner Clint Duane Carlson , and 10 percent owner Double Black Diamond Offshore Ltd .
TFF Pharmaceuticals Inc (TFFP) Insider Trades Summary
Over the past 18 months, Glenn R. Mattes made no insider transaction in TFF Pharmaceuticals Inc (TFFP). Other recent insider transactions involving TFF Pharmaceuticals Inc (TFFP) include a net purchase of 600,000 shares made by Harlan F Weisman , a net sale of 216,000 shares made by Carlson Capital L P , and a net purchase of 120,000 shares made by Zamaneh Mikhak .
In summary, during the past 3 months, insiders sold 0 shares of TFF Pharmaceuticals Inc (TFFP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,640 shares of TFF Pharmaceuticals Inc (TFFP) were sold and 32,800 shares were bought by its insiders, resulting in a net purchase of 24,160 shares.
TFF Pharmaceuticals Inc (TFFP)'s detailed insider trading history can be found in Insider Trading Tracker table.
TFF Pharmaceuticals Inc Insider Transactions
Glenn R. Mattes Mailing Address
Above is the net worth, insider trading, and ownership report for Glenn R. Mattes. You might contact Glenn R. Mattes via mailing address: 200 Route 31 North, Suite 104, Flemington Nj 08822.